| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/30/1991 | US5036053 Diol-containing renin inhibitors |
| 07/24/1991 | EP0438311A2 Di- and tripeptide renin inhibitors |
| 07/24/1991 | EP0437552A1 Alkyl derivates in 17/21 of 19-nor progesterone |
| 07/20/1991 | CA2034524A1 Di- and tripeptide renin inhibitors containing non-peptidal conformationally-constrained tripeptide mimic for leu10-val11-ile12 |
| 07/16/1991 | US5032595 Method of stimulating steroidogenesis with alpidem |
| 07/16/1991 | US5032396 Interleukin-7 |
| 07/09/1991 | US5030772 Condensation of steroidal aldehyde with arylsulfone, reduction of formed adduct with amalgam, followed by conversion to desired vitamin D |
| 07/09/1991 | US5030630 Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone |
| 07/03/1991 | EP0435200A2 Estrogen-containing gel preparation |
| 07/03/1991 | EP0398925A4 Growth inhibiting agent and the use thereof |
| 07/03/1991 | CN1052677A 14 alpha, 17 alpha-ethano-16 alpha-hydroxy-estratriene |
| 07/02/1991 | US5028430 Delivery systems for the controlled administration of LHRH analogs |
| 06/27/1991 | WO1991009831A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use |
| 06/27/1991 | WO1991009137A1 Recombinant thyrotropin receptor |
| 06/27/1991 | WO1991009056A1 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 06/27/1991 | CA2072360A1 Prodrug anhydride compositions |
| 06/27/1991 | CA2046594A1 Octapeptide analogs of somatostatin having threonine at the sixth position |
| 06/26/1991 | EP0434625A2 IGF-I for treating adverse effect of steroid therapy |
| 06/26/1991 | EP0434570A2 Steroid products carrying a substituted thioethyl group in position 10, a process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them |
| 06/26/1991 | EP0434360A1 New benziodiazepine analogs |
| 06/25/1991 | US5026825 With aminolevulinic acid |
| 06/23/1991 | CA2032989A1 Steroid products containing a substituted thioethyl radical in position 10; process and intermediates for preparing the same; their use as therapeutic agents and pharmaceutical compositions containing them |
| 06/19/1991 | CA2032427A1 Benzodiazepines analogs |
| 06/13/1991 | WO1991007974A1 Topical therapeutic preparation |
| 06/05/1991 | EP0430386A1 14Alpha, 17alpha bridged 16-hydroxyestratrienes |
| 06/04/1991 | CA1284636C 17.beta.-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5.alpha.-ANDROSTAN-3-ONES |
| 05/31/1991 | CA2030961A1 Angiotensin ii antagonists |
| 05/30/1991 | WO1991008219A1 14-alpha,17-alpha-bridged 16-hydroxyestratrienes |
| 05/30/1991 | CA2069880A1 14-alpha, 17-alpha-bridged 16-hydroxyestratrienes |
| 05/25/1991 | WO1991007961A1 A method of stimulating steroidogenesis with alpidem |
| 05/25/1991 | CA2045174A1 Method of stimulating steroidogenesis with alpidem |
| 05/22/1991 | CN1051503A Treatment of conditions and disease |
| 05/16/1991 | CA2029940A1 Use of new injectable biodegradable microspheres, process for preparation thereof and injectable suspension comprising them |
| 05/15/1991 | EP0299963B1 Renin inhibitors having a lactam pseudo dipeptide |
| 05/14/1991 | US5015728 Reaction of endopepsidase and insulin, genetic engineering |
| 05/08/1991 | EP0426488A1 Production of modified superoxide dismutase |
| 05/08/1991 | DE3935738A1 Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff A drug containing the human parathyroid hormone-fragment (1-37) as the active drug |
| 05/03/1991 | WO1991006529A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 05/03/1991 | CA2067569A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 05/03/1991 | CA2029216A1 Process of producing modified superoxide dismutase |
| 04/28/1991 | WO1991006564A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE |
| 04/24/1991 | EP0423326A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient |
| 04/24/1991 | EP0423322A1 Grf analogs viia. |
| 04/23/1991 | US5010057 Renin-inhibiting peptides having an aminomethyl side chain |
| 04/17/1991 | EP0422100A1 11-g(b)-SUBSTITUTED PROGESTERONE ANALOGS. |
| 04/16/1991 | CA1283049C Methods for suppressing the endocrine system |
| 03/26/1991 | US5002931 Human Hypothalmic Growth Hormone Releasing Factor |
| 03/22/1991 | WO1991004058A2 Treatment of conditions and disease |
| 03/22/1991 | CA2042034A1 Treatment of conditions and disease |
| 03/20/1991 | EP0417454A2 Reduced size LHRH analogs |
| 03/20/1991 | EP0417165A1 Polypeptide compounds having growth hormone releasing activity. |
| 03/13/1991 | EP0415924A1 Regulation of cell proliferation and differentiation using peptides. |
| 03/12/1991 | CA1281326C N-substituted diphenylpiperidines |
| 03/07/1991 | WO1991002796A1 Cystic fibrosis gene |
| 03/05/1991 | WO1991003487A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
| 03/05/1991 | CA2066449A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
| 02/27/1991 | EP0413750A1 Renin inhibitory peptides containing a substituted phenoxyacetyle group |
| 02/21/1991 | WO1991001994A1 11β-SUBSTITUTED 16α,17α-METHYLENE-ESTRA-4,9-DIENE-3-ONES |
| 02/21/1991 | WO1991001993A1 ANTIGESTAGENIC 11β-ARYL-16α,17α-CYCLOHEXANO-ESTRA-4,9-DIENES |
| 02/21/1991 | WO1991001975A1 Cycloalkylenazoles, process for preparing them, pharmaceutical preparations containing them and their use to manufacture drugs |
| 02/21/1991 | WO1991001958A2 11β-ARYL-GONA-4,9-DIEN-3-ONES |
| 02/20/1991 | CN1049352A Process for preparing ester of organic acid with al cohol derivatives of 19-nor steroids and their salts |
| 02/13/1991 | EP0412907A2 New organic acid esters of alcoholic derivatives of 19-nor steroids and their salts, process for their preparation and intermediates thereof, their use as medicines and pharmaceutical compositions containing them |
| 02/13/1991 | CN1049157A Process for preparing cycloalkanylpyrrole |
| 02/09/1991 | CA2022647A1 Organic acid esters with 19-nor steroids derivated alcools and their salts process for their preparation and intermediates, use as medicaments and compositions containing the same |
| 02/06/1991 | EP0411736A1 11-Beta substituted 16-alpha, 17-alpha-methylene-estra-4,9-dien-3-one |
| 02/06/1991 | EP0411735A1 Cycloalkylenazoles, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicines |
| 02/06/1991 | EP0411734A1 11-Beta-Aryl-16,16-alpha-cyclohexano-estra-4,9-diene progesterone inhibitors |
| 02/06/1991 | EP0411733A2 11-Beta-aryle-gona-4,9-dien-3-ones |
| 02/05/1991 | US4990664 Ethanolamine derivatives |
| 01/29/1991 | US4988684 Novel 4-alkylthio-steroids |
| 01/24/1991 | WO1991000732A1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 01/24/1991 | CA2063378A1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 01/16/1991 | EP0408509A2 Substituted benzonitriles |
| 01/15/1991 | US4985407 Renin Inhibitors, Treating Cardiovascular Disorders, Hypotensive Agents |
| 01/15/1991 | CA2021049A1 Substituted benzonitriles |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/01/1991 | US4981862 Tetrahydrobenzothiazoles, and the preparation and use thereof |
| 01/01/1991 | US4981847 Tricyclic compounds |
| 01/01/1991 | US4981842 Antitumor peptides |
| 12/27/1990 | EP0404652A1 Novel hypothalamic polypeptides with adenylate cyclase stimulating activity |
| 12/19/1990 | EP0402950A2 Treatment of postmenopausal disorders |
| 12/19/1990 | EP0402857A2 Use of 17 beta-Cyclopropylaminoandrostene Derivatives |
| 12/18/1990 | CA1277932C Human calcitonin precursor polyprotein structural gene |
| 12/17/1990 | WO1990015821A1 Stabilized, potent grf analogs |
| 12/17/1990 | CA2057895A1 Stabilized, potent grf analogs |
| 12/12/1990 | EP0401243A1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives. |
| 12/11/1990 | US4977147 Contraceptives, antitumor agents |
| 12/11/1990 | CA1277594C Compounds having somatostatin-like activity useful as local anti-inflammatory agents |
| 12/10/1990 | WO1990015058A1 Heterocyclic amines having central nervous system activity |
| 11/29/1990 | WO1990014354A1 STEROIDS WITH A 9α-HYDROXY-19,11β BRIDGE, THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
| 11/28/1990 | EP0399632A1 9-Alpha-hydroxy-19,11-bêta bridged steroids, their preparation and pharmaceutical compositions containing them |
| 11/28/1990 | EP0399556A1 Amino-substituted heterocycles as renin inhibitors |
| 11/28/1990 | EP0398925A1 Growth inhibiting agent and the use thereof. |
| 11/27/1990 | WO1990014356A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 11/27/1990 | CA2057049A1 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 11/26/1990 | CA2017552A1 Amino-substituted heterocycles as renin inhibitors |
| 11/25/1990 | CA2057878A1 9.alpha.-hydroxy-19,11.beta., bridged steroids, their production and pharmaceutical preparations containing these steroids |
| 11/22/1990 | EP0397834A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 11/20/1990 | CA1276633C Imidazo-pyridine derivatives |